Evidence map›Paper›PMID 39231862›Full record

ArticleJournal of neurology2024

Correction to: Moving towards a new era for the treatment of neuromyelitis optica spectrum disorders.

Paolo Preziosa, Maria Pia Amato, Luca Battistini, Marco Capobianco, Diego Centonze, Eleonora Cocco, Antonella Conte, Claudio Gasperini, Matteo Gastaldi, Carla Tortorella and 1 more

Abstract readPublished Erratum
PubMed Publisher
In one paragraph

Article in Journal of neurology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors.

Paolo PreziosaNeuroimaging Research Unit, Division of Neuroscience, IRCCS San Raffaele Scientific Institute, Milan, Italy.
Maria Pia AmatoDepartment Neurofarba, University of Florence, Florence, Italy.
Luca BattistiniNeuroimmunology Unit, IRCCS Santa Lucia Foundation, Rome, Italy.
Marco CapobiancoNeurology Department, "S. Croce e Carle" Hospital, Cuneo, Italy.
Diego CentonzeDepartment of Systems Medicine, Tor Vergata University, Rome, Italy.
Eleonora CoccoMultiple Sclerosis Center, Binaghi Hospital, ASL Cagliari, Cagliari, Italy.
Antonella ConteUnit of Neurology, IRCCS Neuromed, Pozzilli, Isernia, Italy.
Claudio GasperiniMS Center, Department of Neuroscience, San Camillo Forlanini Hospital, Rome, Italy.
Matteo GastaldiNeuroimmunology Research Section, IRCCS Mondino Foundation, Pavia, Italy.
Carla TortorellaMS Center, Department of Neuroscience, San Camillo Forlanini Hospital, Rome, Italy.
Massimo FilippiNeuroimaging Research Unit, Division of Neuroscience, IRCCS San Raffaele Scientific Institute, Milan, Italy. filippi.massimo@hsr.it.ORCID http://orcid.org/0000-0002-5485-0479

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID39231862

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.